Reference |
---|
Sandberg J, Varnaitė R, Christ W, Chen P, Muvva J, Maleki K, et al. SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation. Clin Transl Immunology. 2021;10:e1306 pubmed publisher
|
Foord E, Arruda L, Gaballa A, Klynning C, Uhlin M. Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci Transl Med. 2021;13: pubmed publisher
|
Smith C, Moraka N, Ibrahim M, Moyo S, Mayondi G, Kammerer B, et al. Human Immunodeficiency Virus Exposure but Not Early Cytomegalovirus Infection Is Associated With Increased Hospitalization and Decreased Memory T-Cell Responses to Tetanus Vaccine. J Infect Dis. 2020;221:1167-1175 pubmed publisher
|
Gibani M, Jones E, Barton A, Jin C, Meek J, Camara S, et al. Investigation of the role of typhoid toxin in acute typhoid fever in a human challenge model. Nat Med. 2019;25:1082-1088 pubmed publisher
|
Levin M, Kroehl M, Johnson M, Hammes A, Reinhold D, Lang N, et al. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest. 2018;128:4429-4440 pubmed publisher
|
Jackson S, Sedikides G, Okecha G, Poole E, Sinclair J, Wills M. Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells. Front Immunol. 2017;8:733 pubmed publisher
|
Uebele J, Stein C, Nguyen M, Schneider A, Kleinert F, Ticha O, et al. Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus. PLoS Pathog. 2017;13:e1006387 pubmed publisher
|
Jackson S, Sedikides G, Mason G, Okecha G, Wills M. Human Cytomegalovirus (HCMV)-Specific CD4+ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In Vitro. J Virol. 2017;91: pubmed publisher
|
Körber N, Behrends U, Hapfelmeier A, Protzer U, Bauer T. Validation of an IFN?/IL2 FluoroSpot assay for clinical trial monitoring. J Transl Med. 2016;14:175 pubmed publisher
|
Brunskole Hummel I, Zitzmann A, Erl M, Wenzel J, Jilg W. Characteristics of immune memory 10-15 years after primary hepatitis B vaccination. Vaccine. 2016;34:636-642 pubmed publisher
|
Brunskole Hummel I, Huber B, Wenzel J, Jilg W. Markers of Protection in Children and Adolescents Six to Fourteen Years After Primary Hepatitis B Vaccination in Real Life: A Pilot Study. Pediatr Infect Dis J. 2016;35:286-91 pubmed publisher
|
Chauvat A, Benhamouda N, Gey A, Lemoine F, Paulie S, Carrat F, et al. Clinical validation of IFN?/IL-10 and IFN?/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humans. Hum Vaccin Immunother. 2014;10:104-13 pubmed publisher
|
Lee F, Walsh E, Falsey A, Lumb M, Okam N, Liu N, et al. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis. 2007;195:1779-88 pubmed
|